(Total Views: 357)
Posted On: 08/09/2017 10:18:52 AM
Post# of 72440
Forbes article: VRTX acquires small company, that acquisition ultimately saves the company (and probably, lots of lives).
Sounds like the IPIX story, we get PYMX's Brilacidin for 5 million bucks, and now it's becoming very important. (Not that Prurisol and Kevetrin are not, but this is a similar case of the tail ending up wagging the dog)
Very good read, will resonate with IPIX shareholders.
https://www.forbes.com/sites/matthewherper/20...626dff5de1
Sounds like the IPIX story, we get PYMX's Brilacidin for 5 million bucks, and now it's becoming very important. (Not that Prurisol and Kevetrin are not, but this is a similar case of the tail ending up wagging the dog)
Very good read, will resonate with IPIX shareholders.
https://www.forbes.com/sites/matthewherper/20...626dff5de1
(5)
(0)Scroll down for more posts ▼
